Telehealth start-up Eucalyptus, which sells weight loss medication rather than the bleeding-edge peptides, has courted plenty of regulatory and media scrutiny
This injury can be a result of a sudden impact or long-term overuse
That means you cannot legitimately place 10.8% for cagrilintide next to 24.2% for retatrutide and declare a winner, because those numbers come from different trials, different populations, different durations (26 vs 48 weeks), different doses, and critically a monotherapy figure for one versus a monotherapy figure for the other, while cagrilintides strongest data are actually as a combination
Nevertheless, Millman promotes his products on social media, primarily TikTok
Athletes, individuals with chronic pain conditions, or those with previous peptide therapy experience often prefer injectable protocols despite the administration complexity